DOCSLIB.ORG

Red Blood Cells – Importance of Film Examination: Part One

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Red Blood Cells – Importance of Film Examination: Part One Vet Times The website for the veterinary profession https://www.vettimes.co.uk RED BLOOD CELLS – IMPORTANCE OF FILM EXAMINATION: PART ONE Author : Mark Richer Categories : Vets Date : March 25, 2013 Mark Richer warns practices to ignore the film comments on a haemotology report at their peril, since the most useful value may be found there Summary This article seeks to demonstrate the appearance of red blood cells (RBCs) on blood smears and to relate their appearance to potential disease processes. Morphological abnormalities of RBCs may help in identifying diseases processes that may be occult or only suspected on physical examination. Examination of RBC morphological changes can be a powerful diagnostic tool that is often underused. Key words red blood cells, haematology, reticulocytes, anaemia, neoplastic, cardiac LOOKING at haematology results many practitioners see “normal figures” and then ignore the haematologist’s comment. In many instances, the film comment gives more information than the numbers, meaning practices that rely on in-house analysers without follow-up film examination may find themselves at a significant disadvantage. In particular, the comments can indicate whether an anaemia is regenerative, or even the presence of inflammatory, neoplastic, cardiac or other diseases. This article aims to help practitioners 1 / 6 interpret the comments to expand their differential diagnoses. The figures can be used to identify RBC morphological changes. Unless otherwise stated, all smears in the figures have been stained with Romanowsky stains. Staining your own blood smears – Quick stains vs Giemsa Staining blood smears can be easily achieved with quick stains, such as Diff-Quik. Quick stains are not true Romanowsky stains. For such quick stains to give the best staining, the smear should be immersed in the first stain (the fixative) for two to three minutes, then 20 to 30 seconds in the eosin stain and then in the basophilic stain, regardless of any manufacturer’s instructions to the contrary. Failure to fix for two to three minutes will lead to poor staining and potentially misleading interpretation. Better staining is achieved with Giemsa or other Romanowsky stains. Quick stains often poorly demonstrate polychromasia and spherocytes, therefore, despite the longer wait for staining, Giemsa is much more useful. Alternatives are Wright’s stain or May- Grunwald-Giemsa. The methods for these stains are shown in Figure 1 . – Normal findings Red blood cells should be normocytic (normal sized) and normochromic (normal in colour); unless this is not the case it is normally not mentioned. A degree of polychromasia and anisocytosis will be seen in normal blood smears. – Abnormal findings Abnormal RBC findings are complex and varied in their interpretation. Such findings are better delineated according to their interpretation. The author will explain the haematologist’s comments in terms of their clinical relevance. Normal polychromasia in dogs is reported as 1+ or 2+ (not often greater than 1+) and anisocytosis up to 1+. In cats normal figures are up to 1+ polychromasia (often 0+) and 1+ anisocytosis. Figures greater than this normally indicate a response by the body to the anaemia. Low PCV/RBC count – Regenerative versus nonregenerative anaemia When the RBC count is depressed it is most important to determine if the anaemia is regenerative. Anaemia only becomes regenerative after acute blood loss (haemorrhage or haemolysis) two to five days afterwards because of the time necessary for an adequate bone marrow response. 2 / 6 Anaemia may only become apparent 12 (often as long as 24) hours or more after haemorrhage (not haemolysis) because of fluid shifts within the body. In particular, it should be remembered sight hounds normally have a high PCV (less than 50 per cent) and, as a result, in such breeds a PCV less than 45 per cent should suggest anaemia. Where there is low-grade chronic bleeding or haemolysis, the regenerative response may be poor or absent and the PCV may still remain normal. If anaemia is regenerative, there should be significant polychromasia (red-blue cells on film examination) and anisocytosis (variation in cell size due to macrocytes, which may or may not be polychromatic). In either species, polychromasia is the most indicative of regeneration. Dogs with regenerative anaemias commonly have target cells and other leptocytes. In regenerative anaemias, in particular in cats, relatively large spherical blue bodies, called Howell-Jolly bodies, may be seen within RBCs – these are nuclear remnants indicating a regenerative response. In markedly regenerative anaemias nucleated RBCs may be seen. Occasionally, basophilic stippling of RBCs may be noted (this is common in cattle with regenerative anaemias, but in small animals is more often seen with lead poisoning). The greater the regenerative response the more profound all these changes will be. The presence of Howell– Jolly bodies and/or nucleated RBCs in the absence of anaemia or with a non-regenerative anaemia may indicate bone marrow diseases. Nucleated RBCs and basophilic stippling may be seen with lead poisoning where there is minimal or no anaemia. Nucleated RBCs may also be seen in other non-anaemic diseases, such as cardiac disease, hyperadrenocorticism or inflammatory conditions. Non-regenerative anaemias lack significant polychromasia and may be normocytic, microcytic (for example, iron deficiency) or macrocytic (for example, FeLV) and hypochromic or normochromic. Reticulocytes Reticulocytes are immature anucleate RBCs that contain residual RNA and mitochondria, aggregated into a reticular pattern when stained with supravital stains (such as New Methylene Blue – note that Methylene Blue and New Methylene Blue are not the same). Reticulocytes can either be termed “aggregate” or “punctate” – dogs produce only aggregate reticulocytes, cats produce both aggregate and punctate reticulocytes. The aggregate reticulocyte is larger appearing and macrocytic on a smear, thereby increasing the degree of anisocytosis and the RBC distribution width (known as RDW), and stains blue-ish with Romanowsky stains. Aggregate reticulocytes are referred to as polychromatic RBCs when seen on Romanowsky-stained smears and their presence on blood smears is termed polychromasia. The degree of polychromasia on a blood smear is at least equivalent to the degree of aggregate reticulocytosis, because all polychromatic cells are reticulocytes, but not all reticulocytes are 3 / 6 polychromatic. Where there is profound polychromasia it can usually be assured that the anaemia is regenerative. The reticulocyte count is of particular use in clarifying when the degree of polychromasia is low (differentiating an early regenerative response from a non-regenerative anaemia), but when there is profound polychromasia the reticulocyte counts often adds no additional useful information because values will always be elevated. It should be remembered the degree of polychromasia (or reticulocytosis) must be appropriate to the severity of the anaemia; the more severe the anaemia the greater the degree of polychromasia (or reticulocytosis) that must be present to indicate a significant regenerative response. Performing a reticulocyte count allows the appropriateness of the regenerative response to be clarified clearly. – Automated reticulocyte counts Some analysers give automated reticulocyte counts. These analysers will count reticulocytes, RBCs with basophilic stippling, Howell-Jolly bodies, parasites and nucleated RBCs as reticulocytes, thereby overestimating the reticulocyte count. The degree to which individual analysers do this varies with the analyser type. Manual methods are more accurate. – Performing the reticulocyte count Reticulocytes can be demonstrated with New Methylene Blue stain. Equal volumes of ethylenediaminetetraacetic acid (EDTA), blood and stain are incubated in a test tube at room temperature for 15 minutes and then a blood smear is made from the solution (do not stain a smear). The percentage of reticulocytes (RP) should be calculated by counting 1,000 RBCs. In dogs and cats only aggregate reticulocytes are counted (but see below). The degree of reticulocytosis can be compared to the severity of the anaemia to determine whether the regenerative response is adequate for the degree of anaemia and so indicative of true regeneration. Several mathematical models are used to assess the appropriateness of the reticulocyte response. Because the RP may overestimate the reticulocyte response, either the absolute reticulocyte count (ARC) is calculated or the corrected reticulocyte percentage (CRP) is calculated: ARC = RP (expressed as a fraction) × RBC count CRP = (RP × patient PCV) / Average PCV for species* *37 per cent for cats, 45 per cent for dogs (sight hounds 55 per cent). 4 / 6 In dogs the reticulocyte production index (RPI) is sometimes calculated (below). This can be useful in severe anaemias as the ARC and CRP may further overestimate the bone marrow response in such circumstances because the reticulocytes released from the bone marrow are more immature and take time to mature in the peripheral blood. RPI = CRP/RMT The RMT is the reticulocyte maturation time. RMT varies with the severity of the anaemia (Table 3). The RPI is not valid for any species other than dogs and remains controversial for dogs. Interpretation of each of these results is shown in Table 1 . – Feline punctate reticulocytes Feline punctate reticulocytes result from maturation of aggregate reticulocytes
Load more

Recommended publications
  • Hemolytic Disease of the Newborn
    Intensive Care Nursery House Staff Manual Hemolytic Disease of the Newborn INTRODUCTION and DEFINITION: Hemolytic Disease of the Newborn (HDN), also known as erythroblastosis fetalis, isoimmunization, or blood group incompatibility, occurs when fetal red blood cells (RBCs), which possess an antigen that the mother lacks, cross the placenta into the maternal circulation, where they stimulate antibody production. The antibodies return to the fetal circulation and result in RBC destruction. DIFFERENTIAL DIAGNOSIS of hemolytic anemia in a newborn infant: -Isoimmunization -RBC enzyme disorders (e.g., G6PD, pyruvate kinase deficiency) -Hemoglobin synthesis disorders (e.g., alpha-thalassemias) -RBC membrane abnormalities (e.g., hereditary spherocytosis, elliptocytosis) -Hemangiomas (Kasabach Merritt syndrome) -Acquired conditions, such as sepsis, infections with TORCH or Parvovirus B19 (anemia due to RBC aplasia) and hemolysis secondary to drugs. ISOIMMUNIZATION A. Rh disease (Rh = Rhesus factor) (1) Genetics: Rh positive (+) denotes presence of D antigen. The number of antigenic sites on RBCs varies with genotype. Prevalence of genotype varies with the population. Rh negative (d/d) individuals comprise 15% of Caucasians, 5.5% of African Americans, and <1% of Asians. A sensitized Rh negative mother produces anti-Rh IgG antibodies that cross the placenta. Risk factors for antibody production include 2nd (or later) pregnancies*, maternal toxemia, paternal zygosity (D/D rather than D/d), feto-maternal compatibility in ABO system and antigen load. (2) Clinical presentation of HDN varies from mild jaundice and anemia to hydrops fetalis (with ascites, pleural and pericardial effusions). Because the placenta clears bilirubin, the chief risk to the fetus is anemia. Extramedullary hematopoiesis (due to anemia) results in hepatosplenomegaly.
    [Show full text]
  • Section 8: Hematology CHAPTER 47: ANEMIA
    Section 8: Hematology CHAPTER 47: ANEMIA Q.1. A 56-year-old man presents with symptoms of severe dyspnea on exertion and fatigue. His laboratory values are as follows: Hemoglobin 6.0 g/dL (normal: 12–15 g/dL) Hematocrit 18% (normal: 36%–46%) RBC count 2 million/L (normal: 4–5.2 million/L) Reticulocyte count 3% (normal: 0.5%–1.5%) Which of the following caused this man’s anemia? A. Decreased red cell production B. Increased red cell destruction C. Acute blood loss (hemorrhage) D. There is insufficient information to make a determination Answer: A. This man presents with anemia and an elevated reticulocyte count which seems to suggest a hemolytic process. His reticulocyte count, however, has not been corrected for the degree of anemia he displays. This can be done by calculating his corrected reticulocyte count ([3% × (18%/45%)] = 1.2%), which is less than 2 and thus suggestive of a hypoproliferative process (decreased red cell production). Q.2. A 25-year-old man with pancytopenia undergoes bone marrow aspiration and biopsy, which reveals profound hypocellularity and virtual absence of hematopoietic cells. Cytogenetic analysis of the bone marrow does not reveal any abnormalities. Despite red blood cell and platelet transfusions, his pancytopenia worsens. Histocompatibility testing of his only sister fails to reveal a match. What would be the most appropriate course of therapy? A. Antithymocyte globulin, cyclosporine, and prednisone B. Prednisone alone C. Supportive therapy with chronic blood and platelet transfusions only D. Methotrexate and prednisone E. Bone marrow transplant Answer: A. Although supportive care with transfusions is necessary for treating this patient with aplastic anemia, most cases are not self-limited.
    [Show full text]
  • Evaluation of Anemia Survey (NHANES III) Data- 9 10-28% of Patients Over 65 Years Are Anemic Mark Wurster, M.D., F.A.C.P
    Anemia - Definition • National Health and Nutrition Examination Evaluation of Anemia Survey (NHANES III) data- 9 10-28% of patients over 65 years are anemic Mark Wurster, M.D., F.A.C.P. 9 One third of these are due to iron, folate, B12 The Ohio State University deficiency alone or in combination 9 One third are due to renal disease, or other chronic inflammatory response 9 One third are due to various primary marrow disorders, malignancies or other disorders Anemia Anemia - Definition Classification Schemes • A simplified approach to anemia, • Most common hematologic disorder emphasizing information already included • Decrease from normal levels of Hgb, Hct, RBC: in the CBC: 9 FlFemales – MHb14/dlMean Hgb = 14 g/dl; -2SD = 12 g /dl • Mean Cellular Volume (MCV) 9 Males – Mean Hgb = 15.5 g/dl; -2SD = 13.5 g/dl • Red Cell Distribution Width (RDW) • Caveat – Anemia is a syndrome, not a disease. • Retic count An abnormal Hgb or Hct should ALWAYS be investigated if confirmed on repeat testing. 1 Anemia Anemia Classification Schemes Classification Schemes • Mean Cellular Volume (MCV) • Red blood cell Distribution Width (RDW) • Decreased MCV (microcytic); < 80 fL 9 A numerical expression of • Normal MCV (normocytic); 80 – 99 fL anisocytosis, or variation in RBC size • Increased MCV (macrocytic); > 100 fL Anemia Anemia Classification Schemes Classification Schemes • Red blood cell Distribution Width (RDW) 9 Normal RDW - representing a uniform population • Red blood cell Distribution Width (RDW) of RBCs with respect to size (actually the standard deviation of red blood cell volume divided by the mean volume) 9 Normal; < or = to app.
    [Show full text]
  • Clinical Pathology Interpretation Barbara Horney
    CLINICAL PATHOLOGY PATHOLOGIE CLINIQUE Clinical pathology interpretation Barbara Horney History, physical examination, and Table 1. Hematologic findings from a lethargic, laboratory findings 4-year-old schipperke 4-year-old, spayed female, schipperke was pre- Blood cell count Reference range A sented because of mild lethargy. Pale mucous mem- White blood cells branes were observed on physical examination. Table 1 (WBC) gives the results of the hematological examination of Total 6.0 X 109/L 6.0-17.1 X 109/L blood at Differential samples taken this time. No significant abnor- segmented 65% 3.85 X 109/L 3.6-11.5 X 109/L malities were identified on the serum biochemical neutrophils profile. eosinophils 2% 0.12 X 109/L 0.01-1.25 X 109/L lymphocytes 27% 1.59 X 109/L 1.0-4.8 X 109/L Interpretation and discussion monocytes 6% 0.35 X 109/L 0.15-1.35 X 109/L Red blood cells The hematology results can be summarized as severe, Total 1.2 X 1012/L 5.5-8.5 X 109/L microcytic, normochromic, nonregenerative anemia nucleated 1/100 WBC <1-2 per 100 WBC associated with marked spherocytosis. spherocytes 4+ microcytosis 2+ The presence of spherocytes is often associated with immune-mediated hemolytic disease [1,2], although Platelets estimated normal hereditary membrane defects [3] and zinc toxicosis [4] in number can also result in spherocyte formation. A direct antibody Reticulocytes 0 X 109/L up to 120 X 109/L test (Coomb's test) was weakly positive. This finding can Hemoglobin 22 g/L 120-180 g/L support the tentative diagnosis of anemia of immune- Hematocrit 0.068 L/L 0.37-0.55 L/L mediated etiology, although this test is subject to both Mean corpuscular false positive and false negative results [2,5].
    [Show full text]
  • Anemia and the QT Interval in Hypertensive Patients
    2084 International Journal of Collaborative Research on Internal Medicine & Public Health Anemia and the QT interval in hypertensive patients Ioana Mozos 1*, Corina Serban 2, Rodica Mihaescu 3 1 Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania 2 Department of Functional Sciences, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania 3 1st Department of Internal Medicine, “Victor Babes” University of Medicine and Pharmacy, Timisoara, Romania * Corresponding Author ; Email: [email protected] Abstract Introduction: A prolonged ECG QT interval duration and an increased QT dispersion (QTd) are predictors of sudden cardiac death. Anemia is known as a marker of adverse outcome in cardiovascular disease. Objective: The aim was to assess the relationship between anemia and QT intervals in hypertensive patients. Method: A total of 72 hypertensive patients underwent standard 12-lead ECG. QT intervals and QT dispersions were manually measured. Complete blood count was also assessed. Result: Linear regression analysis revealed significant associations between prolonged QTc and increased QTd and anemia and macrocytosis, respectively. Multiple regression analysis revealed a significant association between red cell distribution width (RDW) >15% and prolonged heart rate corrected maximal QT interval duration (QTc) and QT interval in lead DII (QTIIc). The most sensitive and specific predictor of prolonged QTc and QTIIc was anisocytosis. Anemia was the most sensitive predictor of
    [Show full text]
  • SEED Haematology Sysmex Educational Enhancement and Development October 2012
    SEED Haematology Sysmex Educational Enhancement and Development October 2012 The red blood cell indices The full blood count has been used in conjunction with the traditional red The complete blood count (CBC) is central to clinical deci- cell indices in order to narrow down the possible causes sion making. This makes it one of the commonest laboratory of anaemia in an individual patient. investigations performed worldwide. Whilst the definition of what constitutes an CBC is influenced by the number Impedance technology and type of parameters measured by different haematology The RBC, HCT and MCV are all closely interrelated as they analysers, the traditional red cell indices that are widely are derived from information obtained from the passage used to classify anaemias are common to all. of cells through the aperture of the impedance channel of an automated haematology analyser. The impedance The laboratory approach to anaemia technology is based on the principle that an electrical field, Anaemia is an extremely common global healthcare prob- created between two electrodes of opposite charge, can lem. However, anaemia is merely a symptom which can be used to count and determine the size of cells. Blood result from a multitude of causes. Effective treatment is cells are poor conductors of electricity. The diluent in which only possible if the underlying cause is correctly identified. they are suspended as they pass through the aperture To this end, several classification systems have been devis- during counting is an isotonic solution which is a good ed. The most useful and widely used classification system conductor of electricity.
    [Show full text]
  • Complete Blood Count in Primary Care
    Complete Blood Count in Primary Care bpac nz better medicine Editorial Team bpacnz Tony Fraser 10 George Street Professor Murray Tilyard PO Box 6032, Dunedin Clinical Advisory Group phone 03 477 5418 Dr Dave Colquhoun Michele Cray free fax 0800 bpac nz Dr Rosemary Ikram www.bpac.org.nz Dr Peter Jensen Dr Cam Kyle Dr Chris Leathart Dr Lynn McBain Associate Professor Jim Reid Dr David Reith Professor Murray Tilyard Programme Development Team Noni Allison Rachael Clarke Rebecca Didham Terry Ehau Peter Ellison Dr Malcolm Kendall-Smith Dr Anne Marie Tangney Dr Trevor Walker Dr Sharyn Willis Dave Woods Report Development Team Justine Broadley Todd Gillies Lana Johnson Web Gordon Smith Design Michael Crawford Management and Administration Kaye Baldwin Tony Fraser Kyla Letman Professor Murray Tilyard Distribution Zane Lindon Lyn Thomlinson Colleen Witchall All information is intended for use by competent health care professionals and should be utilised in conjunction with © May 2008 pertinent clinical data. Contents Key points/purpose 2 Introduction 2 Background ▪ Haematopoiesis - Cell development 3 ▪ Limitations of reference ranges for the CBC 4 ▪ Borderline abnormal results must be interpreted in clinical context 4 ▪ History and clinical examination 4 White Cells ▪ Neutrophils 5 ▪ Lymphocytes 9 ▪ Monocytes 11 ▪ Basophils 12 ▪ Eosinophils 12 ▪ Platelets 13 Haemoglobin and red cell indices ▪ Low haemoglobin 15 ▪ Microcytic anaemia 15 ▪ Normocytic anaemia 16 ▪ Macrocytic anaemia 17 ▪ High haemoglobin 17 ▪ Other red cell indices 18 Summary Table 19 Glossary 20 This resource is a consensus document, developed with haematology and general practice input. We would like to thank: Dr Liam Fernyhough, Haematologist, Canterbury Health Laboratories Dr Chris Leathart, GP, Christchurch Dr Edward Theakston, Haematologist, Diagnostic Medlab Ltd We would like to acknowledge their advice, expertise and valuable feedback on this document.
    [Show full text]
  • Red Blood Cell Morphology in Patients with Β-Thalassemia Minor
    J Lab Med 2017; 41(1): 49–52 Short Communication Carolin Körber, Albert Wölfler, Manfred Neubauer and Christoph Robier* Red blood cell morphology in patients with β-thalassemia minor DOI 10.1515/labmed-2016-0052 Keywords: β-thalassemia minor; erythrocytes; red blood Received July 11, 2016; accepted October 20, 2016; previously published cells; red blood cell morphology. online December 10, 2016 Abstract In β-thalassemias, the examination of a peripheral blood (PB) smear may provide relevant clues to initial diagnosis. Background: A systematic analysis of the occurrence of Complete laboratory investigation consists of the determina- red blood cell (RBC) abnormalities in β-thalassemia minor tion of the complete blood count, assessment of red blood has not been performed to date. This study aimed to iden- cell (RBC) morphology, high performance liquid chroma- tify and quantify the frequency of RBC abnormalities in tography (HPLC), hemoglobin electrophoresis and, where patients with β-thalassemia minor. necessary, DNA analysis [1]. Especially in the clinically Methods: We examined blood smears of 33 patients with severe forms referred to as β-thalassemia major and interme- β-thalassemia minor by light microscopy for the occur- dia, RBC abnormalities are often markedly apparent [2]. In rence of 15 defined RBC abnormalities. In the case of posi- β-thalassemia minor, also called β-thalassemia trait, the car- tivity, the abnormal cells/20 high power fields (HPF) at riers are usually clinically asymptomatic, showing persistent 1000-fold magnification were counted. microcytosis and hypochromia or mild microcytic anemia [1, Results: Anisocytosis, poikilocytosis and target cells 3]. The PB smear may show microcytosis, hypochromia and, (median 42/20 HPF) were observed in all, and ovalocytes infrequently, poikilocytosis [2].
    [Show full text]
  • Vitamin D Insufficiency Is a Frequent Finding in Pediatric and Adult
    al Dis ion ord rit e t rs u N & f T o h l e a r n a Winters et al., J Nutr Disorders Ther 2014, 4:2 r p u y o Journal of Nutritional Disorders & Therapy J DOI: 10.4172/2161-0509.1000140 ISSN: 2161-0509 Research Article Open Access Vitamin D Insufficiency is a Frequent Finding in Pediatric and Adult Patients with Sickle Cell Disease and Correlates with Markers of Cell Turnover Winters AC1, Kethman W2, Kruse-Jarres R3 and Kanter J4* 1Cincinnati Children's Hospital, Burnet Ave, Cincinnati, OH 45229, USA 2Stanford University, Serra Mall, Stanford, CA 94305, USA 3Tulane University, St Charles Ave, New Orleans, LA 70118, USA 4Medical University of South Carolina, Charleston, SC, USA *Corresponding author: Julie Kanter, Director, Sickle Cell Disease Research, MUSC, 135 Rutledge Avenue, MSC 558, Charleston, SC, 29425, USA, Tel: (843) 876-8483; E-mail: [email protected] Rec Date: April 14, 2014, Acc Date: Jun 16, 2014, Pub Date: Jun 18, 2014 Copyright: © 2014 Winters AC, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract Vitamin D insufficiency affects 33%-78% of children and 60-100% of adults with sickle cell disease (SCD). There are no previous reports demonstrating a correlation between vitamin D insufficiency and cell turnover in patients with SCD. We hypothesized that vitamin D insufficiency was prevalent in our SCD population (ages 0-60 years) and would correlate with reticulocyte counts in these patients.
    [Show full text]
  • A Study of the Neonatal Haematology of Children with Down Syndrome
    A study of the neonatal haematology of children with Down syndrome Rebecca James submitted in accordance with the requirements for the degree of Doctor of Philosophy Department of Health Sciences University of York, March 2011 Abstract This thesis describes the establishment and initial findings of the Children with Down Syndrome Study, a birth cohort of children with DS. The Children with Down Syndrome Study was set up in order to characterise the haematology of neonates with Down syndrome and specifically to test the hypothesis that that this differed in this population. The study was carried out with the support of the Down Syndrome Association and the Down Syndrome Medical Interest Group, and through consultation with clinicians and families. Following a pilot study in the Yorkshire region it was established in over 60 hospitals across the north of England. The Children with Down Syndrome Study is the largest birth cohort of children with Down syndrome established to date, and this is the largest reported analysis of the haematology of neonates with Down syndrome. The results confirm that neonates with Down syndrome have a distinct haematological profile. Means and ranges for haematological parameters throughout the neonatal period are provided. The effects of gestational age, birth weight, postnatal age and the venepuncture to processing interval on the neonatal full blood count were examined, and this is the first report of factors that influence the haematological parameters in neonates with Down syndrome. In order to analyse the blood cell morphology a new approach to morphology was developed and validated. Morphological review of samples from neonates with Down syndrome demonstrated that blasts were common.
    [Show full text]
  • 2012 CKD Guideline
    OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY OF NEPHROLOGY KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease VOLUME 3 | ISSUE 1 | JANUARY 2013 http://www.kidney-international.org KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease KDIGO gratefully acknowledges the following consortium of sponsors that make our initiatives possible: Abbott, Amgen, Bayer Schering Pharma, Belo Foundation, Bristol-Myers Squibb, Chugai Pharmaceutical, Coca-Cola Company, Dole Food Company, Fresenius Medical Care, Genzyme, Hoffmann-LaRoche, JC Penney, Kyowa Hakko Kirin, NATCO—The Organization for Transplant Professionals, NKF-Board of Directors, Novartis, Pharmacosmos, PUMC Pharmaceutical, Robert and Jane Cizik Foundation, Shire, Takeda Pharmaceutical, Transwestern Commercial Services, Vifor Pharma, and Wyeth. Sponsorship Statement: KDIGO is supported by a consortium of sponsors and no funding is accepted for the development of specific guidelines. http://www.kidney-international.org contents & 2013 KDIGO VOL 3 | ISSUE 1 | JANUARY (1) 2013 KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease v Tables and Figures vii KDIGO Board Members viii Reference Keys x CKD Nomenclature xi Conversion Factors & HbA1c Conversion xii Abbreviations and Acronyms 1 Notice 2 Foreword 3 Work Group Membership 4 Abstract 5 Summary of Recommendation Statements 15 Introduction: The case for updating and context 19 Chapter 1: Definition, and classification
    [Show full text]
  • Complete Blood Count
    Print Entire Test Page 1 of 6 Close Window email this page print this page Complete Blood Count Also known as: CBC, Hemogram, CBC with differential Related tests: Blood smear, Hemoglobin, Hematocrit, Red blood cell (RBC) count, White blood cell (WBC) count, White blood cell differential count, Platelet count At A Glance Why get tested? To determine general health status and to screen for a variety of disorders, such as anemia and infection When to get tested? As part of a routine medical exam or as determined by your doctor Sample required? A blood sample drawn from a vein in the arm or a fingerstick or heelstick (newborns) The Test Sample What is being tested? The Complete Blood Count (CBC) test is an automated count of the cells in the blood. It provides information about the white blood cell (WBC), red blood cell (RBC), and platelet populations present. This information includes the number, type, size, shape, and some of the physical characteristics of the cells. In only a minute or two, the hematology instrument (the machine that is used to run the test) can measure thousands of RBCs, WBCs, and platelets and compare them against established normal ranges. Any abnormalities found are noted, and the clinical laboratory scientist (CLS) running the instrument then uses his or her expertise and experience to accept the automated findings and/or to target the sample for further analysis. In most cases, the automated CBC is very accurate and the test is complete at this point. If, however, there are significant abnormalities in one or more of the cell populations, a blood smear test may be performed.
    [Show full text]